Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study

Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study

Limited data exist on cytomegalovirus (CMV) antiviral treatment patterns among kidney transplant recipients (KTRs). Using United States Renal Database System registry data and Medicare claims (1 January 2011–31 December 2017), we examined CMV antiviral use in 20,601 KTRs who received their first KT...

Full description

Bibliographic Details
Main Authors:	Amit D. Raval, Michael L. Ganz, Kathy Fraeman, Andrea L. Lorden, Shanmugapriya Saravanan, Yuexin Tang, Carlos A. Q. Santos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Transplant International
Subjects:	kidney transplantation antiviral cytomegalovirus prophylaxis pharmacoepidemiology
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2022.10528/full

Similar Items

Corrigendum: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
by: Amit D. Raval, et al.
Published: (2024-02-01)

Cytomegalovirus DNAemia in kidney transplant recipients after cessation of standard antiviral prophylaxis; estimated rate on Thai cases and implication on efficacy of prophylaxis
by: Won Sriwijitalai, et al.
Published: (2019-05-01)

Antiviral prophylaxis or preemptive therapy for cytomegalovirus after liver transplantation?: A systematic review and meta-analysis
by: Dipesh Kumar Yadav, et al.
Published: (2022-11-01)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
by: Evi B. Struble, et al.
Published: (2021-08-01)

CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
by: O. M. Tsiroulnikova, et al.
Published: (2016-04-01)

Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
by: Martyna Wlodarczyk, et al.
Published: (2024-03-01)

Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation
by: Albekairy AM, et al.
Published: (2022-06-01)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
by: Woo Yeong Park, et al.
Published: (2020-03-01)

Cytomegalovirus Infection in Kidney Transplant Recipients
by: Dino Šisl, et al.
Published: (2021-04-01)

Expression of Concern: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
by: Transplant International Editorial Office
Published: (2023-11-01)

Resistant cytomegalovirus infection in related donor kidney allograft recipients
by: V A Goryainov, et al.
Published: (2016-06-01)

Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
by: Oriol Bestard, et al.
Published: (2023-11-01)

Targeting the Host Mitochondria as a Novel Human Cytomegalovirus Antiviral Strategy
by: Lauryn O. Bachman, et al.
Published: (2023-04-01)

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
by: Moritz Benjamin Immohr, et al.
Published: (2023-11-01)

Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation
by: Ana-Belén Pérez, et al.
Published: (2023-12-01)

Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection
by: Matteo Biolatti, et al.
Published: (2020-05-01)

Cytomegalovirus enteritis resistant to antiviral drugs improved following total colectomy
by: Sae Kawata, et al.
Published: (2023-06-01)

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
by: Tomas Reischig, et al.
Published: (2018-11-01)

Peroxisomes as Platforms for Cytomegalovirus’ Evasion from Cellular Antiviral Signaling
by: Ana Rita Ferreira, et al.
Published: (2020-06-01)

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
by: Katharina Göhring, et al.
Published: (2015-01-01)

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
by: Eun Jeong Ko, et al.
Published: (2019-03-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01)

Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection
by: Jiang Deng, et al.
Published: (2017-05-01)

Cytomegalovirus infection after kidney transplantation: real progress and prospects for pathogenesis research, prevention and treatment
by: E. I. Prokopenko
Published: (2019-10-01)

Cytomegalovirus Disease Causing Outbreak in Family Members
by: Hüsnü PULLUKÇU, et al.
Published: (2019-09-01)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
by: Linda A. Selvey, et al.
Published: (2017-07-01)

Evaluation of the effectiveness of prophylactic strategies for cytomegalovirus infection in pediatric kidney recipients
by: O. M. Tsirulnikova, et al.
Published: (2022-01-01)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed
by: Rachid Tahiri Joutei Hassani, et al.
Published: (2020-06-01)

Antiviral Resistance in Human Cytomegalovirus Due to UL54 Mutations Without UL97 Mutations
by: Kuenyoul Park, et al.
Published: (2022-06-01)

Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan
by: Chao-Neng Cheng, et al.
Published: (2022-04-01)

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
by: Jocelyne Piret, et al.
Published: (2024-01-01)

Synchronous cytomegalovirus infection in a newly diagnosed ulcerative colitis patient
by: Jin Yu Chieng, et al.
Published: (2017-12-01)

Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco
by: Rezzouk B, et al.
Published: (2021-01-01)

The beneficial impact of filtration surgery on antiviral therapy cessation in patients with cytomegalovirus-related secondary glaucoma
by: Yusuke Murai, et al.
Published: (2021-11-01)

Treatment of cytomegalovirus retinitis
by: B. S. Pershin, et al.
Published: (2019-11-01)

Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
by: Robert Breitkopf, et al.
Published: (2023-08-01)

Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance
by: Jocelyn Hume, et al.
Published: (2023-05-01)

Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation under 100-Day Letermovir Prophylaxis: A Real-World 1-Year Follow-Up Study
by: Dukhee Nho, et al.
Published: (2023-09-01)

Change in Viral Load during Antiviral Therapy Is Not Useful for the Prediction of Hearing Dysfunction in Symptomatic Congenital Cytomegalovirus Infection
by: Takumi Kido, et al.
Published: (2021-12-01)